Choi, Y. J., Byun, Y., Kang, J. S., Kim, H. S., Han, Y., Kim, H., . . . Jang, J. (2021). Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX. Gut Liver.
Citación estilo ChicagoChoi, Yoo Jin, et al. "Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine Versus FOLFIRINOX." Gut Liver 2021.
Cita MLAChoi, Yoo Jin, et al. "Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine Versus FOLFIRINOX." Gut Liver 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.